Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $2.5500 (-2.86%) ($2.5500 - $2.5500) on Mon. Apr. 18, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.92% (three month average) | RSI | 31 | Latest Price | $2.5500(-2.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -2.2% a day on average for past five trading days. | Weekly Trend | CGEN declines -9.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) IWF(96%) SPY(97%) IVE(96%) SKYY(96%) VUG(96%) | Factors Impacting CGEN price | CGEN will decline at least -1.96% in a week (0% probabilities). UNG(-40%) TIP(-14%) UUP(-12%) SHY(-4%) TBT(2%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.96% (StdDev 3.92%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-12.52(-590.98%) | Resistance Level | $3.08 | 5 Day Moving Average | $2.69(-5.2%) | 10 Day Moving Average | $2.9(-12.07%) | 20 Day Moving Average | $3.08(-17.21%) | To recent high | -32.9% | To recent low | 0% | Market Cap | $211m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |